| human | Q5 |
| P2287 | CRIStin ID | 37186 |
| P213 | ISNI | 0000000491016082 |
| P1015 | NORAF ID | 98019256 |
| P496 | ORCID iD | 0000-0002-8582-6965 |
| P214 | VIAF ID | 1366149198209374940006 |
| P27 | country of citizenship | Norway | Q20 |
| P108 | employer | Norwegian University of Science and Technology | Q314536 |
| P734 | family name | Bathen | Q37257255 |
| Bathen | Q37257255 | ||
| Bathen | Q37257255 | ||
| P735 | given name | Tone | Q12804282 |
| Tone | Q12804282 | ||
| P106 | occupation | professor | Q121594 |
| researcher | Q1650915 | ||
| P21 | sex or gender | female | Q6581072 |
| Q39382153 | 2-hydroxyglutarate as a magnetic resonance biomarker for glioma subtyping |
| Q35996026 | A Balanced Tissue Composition Reveals New Metabolic and Gene Expression Markers in Prostate Cancer |
| Q48243611 | A PET/MRI study towards finding the optimal [18F]Fluciclovine PET protocol for detection and characterisation of primary prostate cancer |
| Q99605085 | A Quality Control System for Automated Prostate Segmentation on T2-Weighted MRI |
| Q50226997 | A Simplified Approach to Measure the Effect of the Microvasculature in Diffusion-weighted MR Imaging Applied to Breast Tumors: Preliminary Results |
| Q37706021 | A novel non-canonical Wnt signature for prostate cancer aggressiveness |
| Q52653007 | APIM-peptide targeting PCNA improves the efficacy of docetaxel treatment in the TRAMP mouse model of prostate cancer. |
| Q91880935 | Accuracy of breast cancer lesion classification using intravoxel incoherent motion diffusion-weighted imaging is improved by the inclusion of global or local prior knowledge with bayesian methods |
| Q51635006 | Alignment of high resolution magic angle spinning magnetic resonance spectra using warping methods. |
| Q39817719 | Assessment of early docetaxel response in an experimental model of human breast cancer using DCE-MRI, ex vivo HR MAS, and in vivo 1H MRS. |
| Q31000275 | Bioactive compounds in cod (Gadus morhua) products and suitability of 1H NMR metabolite profiling for classification of the products using multivariate data analyses |
| Q64067663 | Breast cancer quantitative proteome and proteogenomic landscape |
| Q47337235 | Cerebral metabolite differences in adolescents with low birth weight: assessment with in vivo proton MR spectroscopy |
| Q44785789 | Cervical cancer tissue characterized by high-resolution magic angle spinning MR spectroscopy |
| Q43812454 | Characterization of brain metastases using high-resolution magic angle spinning MRS. |
| Q115612338 | Characterization of the diffusion signal of breast tissues using multi‐exponential models |
| Q54960557 | Cholesterol synthesis pathway genes in prostate cancer are transcriptionally downregulated when tissue confounding is minimized. |
| Q49547411 | Combined (18)F-Fluciclovine PET/MRI shows potential for detection and characterization of high-risk prostate cancer |
| Q47185720 | Combining clinical assessment scores and in vivo MR spectroscopy neurometabolites in very low birth weight adolescents |
| Q46756319 | Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters |
| Q44844537 | Differentiating diffuse World Health Organization grade II and IV astrocytomas with ex vivo magnetic resonance spectroscopy |
| Q40400935 | Diffusion weighted imaging for the differentiation of breast tumors: From apparent diffusion coefficient to high order diffusion tensor imaging |
| Q101225424 | Discrimination of breast cancer from healthy breast tissue using a three-component diffusion-weighted MRI model |
| Q43052904 | Discrimination of patients with microsatellite instability colon cancer using 1H HR MAS MR spectroscopy and chemometric analysis |
| Q57670947 | Distinct First Trimester Cytokine Profiles for Gestational Hypertension and Preeclampsia |
| Q40010957 | Effect of dietary tetradecylthioacetic acid on colon cancer growth studied by dynamic contrast enhanced MRI. |
| Q89996931 | Effect of exercise training on cardiac metabolism in rats with heart failure |
| Q51616949 | Estrogen Receptor α Promotes Breast Cancer by Reprogramming Choline Metabolism. |
| Q50260314 | Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy |
| Q34684585 | Feasibility of MR metabolomics for immediate analysis of resection margins during breast cancer surgery |
| Q91341932 | Feasibility of contrast-enhanced MRI derived textural features to predict overall survival in locally advanced breast cancer |
| Q36184116 | First Trimester Urine and Serum Metabolomics for Prediction of Preeclampsia and Gestational Hypertension: A Prospective Screening Study |
| Q35223291 | Gene signatures ESC, MYC and ERG-fusion are early markers of a potentially dangerous subtype of prostate cancer |
| Q38598175 | Geometric distortion correction in prostate diffusion-weighted MRI and its effect on quantitative apparent diffusion coefficient analysis |
| Q42637114 | Glycerophosphocholine (GPC) is a poorly understood biomarker in breast cancer |
| Q37784533 | HR MAS MR spectroscopy in metabolic characterization of cancer |
| Q57095431 | High tumor glycine concentration is an adverse prognostic factor in locally advanced rectal cancer |
| Q36410307 | High-Quality 3-Dimensional 1H Magnetic Resonance Spectroscopic Imaging of the Prostate Without Endorectal Receive Coil Using A Semi-LASER Sequence |
| Q45047884 | High-resolution magic angle spinning and 1H magnetic resonance spectroscopy reveal significantly altered neuronal metabolite profiles in CLN1 but not in CLN3. |
| Q57095807 | High-resolution magic-angle-spinning NMR spectroscopy of intact tissue |
| Q91442535 | Historical Biobanks in Breast Cancer Metabolomics- Challenges and Opportunities |
| Q38976997 | IDH1 R132H mutation generates a distinct phospholipid metabolite profile in glioma |
| Q36309599 | Identification of Metastasis-Associated Metabolic Profiles of Tumors by (1)H-HR-MAS-MRS |
| Q35522894 | Identification of metabolites from 2D (1)H-(13)C HSQC NMR using peak correlation plots |
| Q30777660 | Impacts of MR spectroscopic imaging on glioma patient management |
| Q34101555 | In vivo MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts |
| Q34016780 | In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response |
| Q42454329 | In vivo ³¹P magnetic resonance spectroscopic imaging (MRSI) for metabolic profiling of human breast cancer xenografts |
| Q35497704 | Increased levels of choline metabolites are an early marker of docetaxel treatment response in BRCA1-mutated mouse mammary tumors: an assessment by ex vivo proton magnetic resonance spectroscopy |
| Q46819629 | Inhomogeneous static magnetic field-induced distortion correction applied to diffusion weighted MRI of the breast at 3T. |
| Q37728699 | Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome |
| Q57094654 | Integrative metabolic and transcriptomic profiling of prostate cancer tissue containing reactive stroma |
| Q37689772 | Interplay of choline metabolites and genes in patient-derived breast cancer xenografts |
| Q47879262 | In vivo MR spectroscopy predicts high tumor grade in endometrial cancer |
| Q46383763 | Lactate and glycine-potential MR biomarkers of prognosis in estrogen receptor-positive breast cancers |
| Q36680439 | Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer |
| Q40276305 | MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status |
| Q37779171 | Magnetic resonance metabolomics of intact tissue: a biotechnological tool in cancer diagnostics and treatment evaluation |
| Q57067804 | Markers of Mitochondrial Metabolism in Tumor Hypoxia, Systemic Inflammation, and Adverse Outcome of Rectal Cancer |
| Q33748176 | Merging transcriptomics and metabolomics--advances in breast cancer profiling |
| Q33844930 | Metabolic Portraits of Breast Cancer by HR MAS MR Spectroscopy of Intact Tissue Samples |
| Q34941232 | Metabolic changes in psoriatic skin under topical corticosteroid treatment |
| Q34967995 | Metabolic characterization of triple negative breast cancer |
| Q37040438 | Metabolic clusters of breast cancer in relation to gene- and protein expression subtypes |
| Q33269605 | Metabolic mapping by use of high-resolution magic angle spinning 1H MR spectroscopy for assessment of apoptosis in cervical carcinomas |
| Q43104456 | Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia |
| Q36590191 | Metabolic profiles of brain metastases |
| Q57095506 | Metabolic profiles of placenta in preeclampsia using HR-MAS MRS metabolomics |
| Q33292251 | Metabolic profiling of human brain metastases using in vivo proton MR spectroscopy at 3T. |
| Q58589109 | Metabolite and lipoprotein responses and prediction of weight gain during breast cancer treatment |
| Q35122808 | Metabolomic biomarkers in serum and urine in women with preeclampsia |
| Q53213556 | Monitoring neoadjuvant chemotherapy in breast cancer patients: improved MR assessment at 3 T? |
| Q34041364 | Monitoring the Effect of Docetaxel Treatment in MCF7 Xenografts Using Multimodal In Vivo and Ex Vivo Magnetic Resonance Methods, Histopathology, and Gene Expression |
| Q43227553 | Multivariate modeling and prediction of breast cancer prognostic factors using MR metabolomics |
| Q88409664 | NMR-based metabolomics of biofluids in cancer |
| Q46135358 | Omega-3 fatty acids suppress growth of SW620 human colon cancer xenografts in nude mice. |
| Q57670984 | P47. First trimester urine and serum metabolomics to predict preeclampsia and gestational hypertension |
| Q40804311 | PP002. Metabolomic biomarkers in serum and urine of preeclamptic women |
| Q51541687 | Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling. |
| Q51827188 | Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE-MRI. |
| Q49979397 | Prediction of Clinical Endpoints in Breast Cancer Using NMR Metabolic Profiles |
| Q30903618 | Preprocessing of NMR metabolomics data |
| Q37520447 | Presence of TMPRSS2-ERG is associated with alterations of the metabolic profile in human prostate cancer |
| Q36649292 | Principal component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning 1H magnetic resonance spectroscopy |
| Q34140986 | Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy |
| Q45728978 | Prognostic value of pretreatment dynamic contrast-enhanced MR imaging in breast cancer patients receiving neoadjuvant chemotherapy: overall survival predicted from combined time course and volume analysis |
| Q43184186 | Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy |
| Q42441848 | Quantitative (31)P HR-MAS MR spectroscopy for detection of response to PI3K/mTOR inhibition in breast cancer xenografts |
| Q91635025 | Relative Enhanced Diffusivity in Prostate Cancer: Protocol Optimization and Diagnostic Potential |
| Q46644059 | Relative enhanced diffusivity: noise sensitivity, protocol optimization, and the relation to intravoxel incoherent motion |
| Q45723424 | SFRP4 gene expression is increased in aggressive prostate cancer |
| Q28481679 | Serum levels of choline-containing compounds are associated with aerobic fitness level: the HUNT-study |
| Q59327159 | Simultaneous 18F-fluciclovine Positron Emission Tomography and Magnetic Resonance Spectroscopic Imaging of Prostate Cancer |
| Q60303727 | Skeletal muscle metabolism in rats with low and high intrinsic aerobic capacity: Effect of aging and exercise training |
| Q34693066 | Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressiveness |
| Q91975859 | Stromal Collagen Content in Breast Tumors Correlates With In Vivo Diffusion-Weighted Imaging: A Comparison of Multi b-Value DWI With Histologic Specimen From Benign and Malignant Breast Lesions |
| Q45944847 | Support vector machine for breast cancer classification using diffusion-weighted MRI histogram features: Preliminary study. |
| Q64076908 | The Effect of Exercise Training on Myocardial and Skeletal Muscle Metabolism by MR Spectroscopy in Rats with Heart Failure |
| Q31042659 | Three-dimensional MR spectroscopic imaging using adiabatic spin echo and hypergeometric dual-band suppression for metabolic mapping over the entire brain |
| Q42726465 | Tissue Microstructure Is Linked to MRI Parameters and Metabolite Levels in Prostate Cancer |
| nb | Tone Frost Bathen | wikipedia |
Search more.